Sina Hübener
Dr. med.
Sina Hübener
  • Medical specialist
  • Medical Specialist in Internal Medicine
Working area

Contact

Location

Main Building O10 , 2nd Floor
Languages
German (Mother tongue)
English

Areas of expertise

Memberships

Publications

Zurück
  • 2024
  • 2023
  • 2022
  • 2021
  • 2019
  • 2016
  • 2015
  • 2014
  • 2013
  • 2007
Vor

Intestinal epithelia and myeloid immune cells shape colitis severity and colorectal carcinogenesis via High-mobility group box protein 1
Foelsch K, Pelczar P, Zierz E, Kondratowicz S, Qi M, Müller C, Alawi M, Huebener S, Clauditz T, Gagliani N, Huber S, Huebener P
J CROHNS COLITIS. 2024 [Epub ahead of print].

A prospective pilot study of a gluten-free diet for primary sclerosing cholangitis and associated colitis
Liwinski T, Hübener S, Henze L, Hübener P, Heinemann M, Tetzlaff M, Hiller M, Jagemann B, Surabattula R, Leeming D, Karsdal M, Monguzzi E, Schachschal G, Rösch T, Bang C, Franke A, Lohse A, Schuppan D, Schramm C
ALIMENT PHARM THER. 2023;57(2):224-236.

Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT)
Löwe B, Nestoriuc Y, Andresen V, Vettorazzi E, Zapf A, Hübener S, Maehder K, Peters L, Lohse A
BMJ OPEN. 2022;12(6):.

A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease
Schuppan D, Mäki M, Lundin K, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho M, Fusco S, Schumann M, Török H, Kupcinskas J, Zopf Y, Lohse A, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R
NEW ENGL J MED. 2021;385(1):35-45.

Zöliakie und Weizensensitivität im Wandel - ein Update
Hübener S, Manthey C
Gastroenterologie up2date. 2019;15(04):375-393.

Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis
Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, Hübener S, Pannicke N, Weiler-Normann C, Quaas A, Lohse A, Schramm C
J HEPATOL. 2016;65(4):769-75.

Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance
Hübener S, Oo Y, Than N, Hübener P, Weiler-Normann C, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2016;14(3):445-453.

Reply to: Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance.
Hübener S, Than N, Oo Y, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2016;14(7):1063-4.

No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis
Zenouzi R, Weismüller T, Jørgensen K, Bubenheim M, Lenzen H, Hübener P, Schulze K, Weiler-Normann C, Sebode M, Ehlken H, Pannicke N, Hartl J, Peiseler M, Hübener S, Karlsen T, Boberg K, Manns M, Lohse A, Schramm C
CLIN GASTROENTEROL H. 2016;14(12):1806-1812.

Intestinal microbiota modulates gluten-induced immunopathology in humanized mice
Galipeau H, McCarville J, Huebener S, Litwin O, Meisel M, Jabri B, Sanz Y, Murray J, Jordana M, Alaedini A, Chirdo F, Verdu E
AM J PATHOL. 2015;185(11):2969-82.

Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response
Huebener S, Tanaka C, Uhde M, Zone J, Vensel W, Kasarda D, Beams L, Briani C, Green P, Altenbach S, Alaedini A
J PROTEOME RES. 2015;14(1):503-11.

Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten
Moeller S, Canetta P, Taylor A, Arguelles-Grande C, Snyder H, Green P, Kiryluk K, Alaedini A
PLOS ONE. 2014;9(4):e94677.

Lack of association between autism and anti-GM1 ganglioside antibody
Moeller S, Lau N, Green P, Hellberg D, Higgins J, Rajadhyaksha A, Alaedini A
NEUROLOGY. 2013;81(18):1640-1.

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis.
Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, Hübener S, Lohse A
J HEPATOL. 2013;58(3):529-534.

Extracellular NAD and ATP: Partners in immune cell modulation.
Haag F, Adriouch S, Brass A, Jung C, Hübener S, Scheuplein F, Bannas P, Seman M, Koch-Nolte F
PURINERG SIGNAL. 2007;3(1-2):71-81.

Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation.
Hübener S, Jung C, Adriouch S, Dubberke G, Seyfried F, Seman M, Haag F, Koch Nolte F
PURINERG SIGNAL. 2007;3(4):359-366.

Letzte Aktualisierung aus dem FIS: 19.04.2024 - 06:31 Uhr